Evergreen Capital Management’s Zentalis Pharmaceuticals ZNTL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $19.6K | Hold |
16,915
| – | – | ﹤0.01% | 1124 |
|
|
2025
Q1 | $26.9K | Hold |
16,915
| – | – | ﹤0.01% | 1083 |
|
|
2024
Q4 | $51.3K | Hold |
16,915
| – | – | ﹤0.01% | 1057 |
|
|
2024
Q3 | $62.2K | Hold |
16,915
| – | – | ﹤0.01% | 990 |
|
|
2024
Q2 | $69.2K | Sell |
16,915
-98
| -0.6% | -$401 | ﹤0.01% | 930 |
|
|
2024
Q1 | $268K | Buy |
17,013
+98
| +0.6% | +$1.54K | 0.01% | 675 |
|
|
2023
Q4 | $256K | Hold |
16,915
| – | – | 0.01% | 665 |
|
|
2023
Q3 | $339K | Hold |
16,915
| – | – | 0.01% | 512 |
|
|
2023
Q2 | $477K | Hold |
16,915
| – | – | 0.02% | 403 |
|
|
2023
Q1 | $291K | Hold |
16,915
| – | – | 0.01% | 522 |
|
|
2022
Q4 | $341K | Hold |
16,915
| – | – | 0.02% | 449 |
|
|
2022
Q3 | $366K | Buy |
+16,915
| New | +$366K | 0.02% | 400 |
|